OTC Markets EXMKT - Delayed Quote USD
Viveve Medical, Inc. (VIVE)
0.0002
0.0000
(0.00%)
At close: April 28 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2021
12/31/2020
Total Revenue
6,826
6,426
5,479
Cost of Revenue
5,707
5,806
5,183
Gross Profit
1,119
620
296
Operating Expense
22,261
22,173
18,791
Operating Income
-21,142
-21,553
-18,495
Net Non Operating Interest Income Expense
-1,112
-1,000
-910
Other Income Expense
-90
782
-2,127
Pretax Income
-22,344
-21,771
-21,532
Earnings from Equity Interest Net of Tax
-645
-256
-383
Net Income Common Stockholders
-28,135
-26,718
-26,064
Diluted NI Available to Com Stockholders
-28,135
-26,718
-26,064
Basic EPS
-2.65
-2.65
-16.56
Diluted EPS
-2.65
-2.65
-16.56
Basic Average Shares
10,633.7940
10,089.7220
1,573.5280
Diluted Average Shares
10,698.8570
10,089.7220
1,573.5280
Total Operating Income as Reported
-21,142
-21,553
-18,495
Total Expenses
27,968
27,979
23,974
Net Income from Continuing & Discontinued Operation
-22,989
-22,027
-21,915
Normalized Income
-22,989
-23,012
-20,077
Interest Expense
1,112
1,000
910
Net Interest Income
-1,112
-1,000
-910
EBIT
-21,232
-20,771
-20,622
EBITDA
-20,426
-19,632
-19,325
Reconciled Cost of Revenue
5,707
5,806
5,183
Reconciled Depreciation
806
1,139
1,297
Net Income from Continuing Operation Net Minority Interest
-22,989
-22,027
-21,915
Total Unusual Items Excluding Goodwill
--
985
-1,838
Total Unusual Items
--
985
-1,838
Normalized EBITDA
-20,426
-20,617
-17,487
12/31/2020 - 3/3/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade